Puneet S. Arora - 24 Feb 2025 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol
SKYE
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
4
Filing time
26 Feb 2025, 17:34:18 UTC
Previous filing
04 Sep 2024
Next filing
09 Feb 2026

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Stock Option (Right to Buy) Award $0 +38,000 $0.000000 38,000 24 Feb 2025 Common Stock 38,000 $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 25% on the one year anniversary of February 21, 2025 and 1/48th monthly thereafter.